{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:08:58Z","timestamp":1794852538656,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RES\/0190\/7915"],"award-info":[{"award-number":["RES\/0190\/7915"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CRUKD\/12\/004"],"award-info":[{"award-number":["CRUKD\/12\/004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RES\/0190\/7915"],"award-info":[{"award-number":["RES\/0190\/7915"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health","doi-asserted-by":"publisher","award":["RES\/0190\/7915"],"award-info":[{"award-number":["RES\/0190\/7915"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,4,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A 47-year-old man with metastatic melanoma presented with refractory hyperlactaemic acidosis following the first dose of the mono-carboxylase transporter 1 inhibitor AZD3965 within a \u201cfirst time in man\u201d clinical trial. The mechanism of the agent and the temporal relationship suggested that this event was potentially drug related and recruitment was suspended. However, urinary metabolomics showed extensive abnormalities even prior to drug administration, leading to investigations for an underlying metabolic disorder. The lack of clinical symptoms from the elevated lactate and low blood glucose suggested a diagnosis of \u201chyper-Warburgism\u201d, where the high tumour burden was associated with extensive glucose uptake and lactate efflux from malignant cells, and the subsequent impact on blood biochemistry. This was supported by an FDG-PET scan showing extensive glucose uptake in numerous metastases and lack of uptake in the brain. A review of the literature showed 16 case reports of \u201chyper-Warburgism\u201d in non-haematological malignancies, none of them with melanoma, with most associated with a poor outcome. The patient was treated symptomatically, but died 2 months later. The development of AZD3965 continues with the exclusion of patients with elevated plasma lactate at screening added to the protocol as a safety measure.<\/jats:p><jats:p><jats:bold>Trial identification number<\/jats:bold> ClinicalTrials.Gov. NCT01791595.<\/jats:p>","DOI":"10.1038\/s41416-020-0727-8","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:05:16Z","timestamp":1582157116000},"page":"1141-1145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965"],"prefix":"10.1038","volume":"122","author":[{"given":"Rosie","family":"McNeillis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Greystoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7358-8851","authenticated-orcid":false,"given":"Hector","family":"Keun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Siskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Petrides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Leech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Bowron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Halford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"key":"727_CR1","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1100\/tsw.2011.125","volume":"11","author":"JP Ruiz","year":"2011","unstructured":"Ruiz, J. P., Singh, A. K. & Hart, P. Type B lactic acidosis secondary to malignancy: case report, review of published cases, insights into pathogenesis, and prospects for therapy. ScientificWorldJournal 11, 1316\u20131324 (2011).","journal-title":"ScientificWorldJournal"},{"key":"727_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"727_CR3","first-page":"120","volume":"69","author":"R de Groot","year":"2011","unstructured":"de Groot, R., Sprenger, R. A., Imholz, A. L. & Gerding, M. N. Type B lactic acidosis in solid malignancies. Neth. J. Med. 69, 120\u2013123 (2011).","journal-title":"Neth. J. Med."},{"key":"727_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/GIM.0b013e31818b0d9b","volume":"10","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis, R. J. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med. 10, 767\u2013777 (2008).","journal-title":"Genet Med."},{"key":"727_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"727_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1159\/000485242","volume":"10","author":"JC van der Mijn","year":"2017","unstructured":"van der Mijn, J. C., Kuiper, M. J., Siegert, C. E. H., Wassenaar, A. E., van Noesel, C. J. M. & Ogilvie, A. C. Lactic acidosis in prostate cancer: consider the Warburg effect. Case Rep. Oncol. 10, 1085\u20131091 (2017).","journal-title":"Case Rep. Oncol."},{"key":"727_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11\u201320 (2008).","journal-title":"Cell Metab."},{"key":"727_CR8","doi-asserted-by":"publisher","first-page":"e65283","DOI":"10.1371\/journal.pone.0065283","volume":"8","author":"HJ Kim","year":"2013","unstructured":"Kim, H. J., Son, Y. K. & An, W. S. Effect of sodium bicarbonate administration on mortality in patients with lactic acidosis: a retrospective analysis. PLoS ONE 8, e65283 (2013).","journal-title":"PLoS ONE"},{"key":"727_CR9","doi-asserted-by":"publisher","first-page":"627673","DOI":"10.1155\/2014\/627673","volume":"2014","author":"MM Adeva-Andany","year":"2014","unstructured":"Adeva-Andany, M. M., Fernandez-Fernandez, C., Mourino-Bayolo, D., Castro-Quintela, E. & Dominguez-Montero, A. Sodium bicarbonate therapy in patients with metabolic acidosis. ScientificWorldJournal 2014, 627673 (2014).","journal-title":"ScientificWorldJournal"},{"issue":"Suppl 17","key":"727_CR10","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1681\/ASN.V12suppl_1s15","volume":"12","author":"FC Luft","year":"2001","unstructured":"Luft, F. C. Lactic acidosis update for critical care clinicians. J. Am. Soc. Nephrol. 12(Suppl 17), S15\u2013S19 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"727_CR11","doi-asserted-by":"crossref","first-page":"232470961878810","DOI":"10.1177\/2324709618788101","volume":"6","author":"B Gharia","year":"2018","unstructured":"Gharia, B., Seegobin, K., Mahida, H., Shaikh, M., Matthews Hew, T. & Pham, D. Fatal type B lactic acidosis associated with metastatic colorectal cancer: a case report with review of literature, pathogenesis, and treatment. J. Investig. Med. High. Impact Case Rep. 6, 2324709618788101 (2018).","journal-title":"J. Investig. Med. High. Impact Case Rep."},{"key":"727_CR12","doi-asserted-by":"publisher","first-page":"32748","DOI":"10.18632\/oncotarget.4977","volume":"6","author":"A Koch","year":"2015","unstructured":"Koch, A., Lang, S. A., Wild, P. J., Gantner, S., Mahli, A., Spanier, G. et al. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells. Oncotarget 6, 32748\u201332760 (2015).","journal-title":"Oncotarget"},{"key":"727_CR13","doi-asserted-by":"publisher","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","volume":"286","author":"DA Scott","year":"2011","unstructured":"Scott, D. A., Richardson, A. D., Filipp, F. V., Knutzen, C. A., Chiang, G. G., Ronai, Z. A. et al. Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J. Biol. Chem. 286, 42626\u201342634 (2011).","journal-title":"J. Biol. Chem."},{"key":"727_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/onc.2016.198","volume":"36","author":"BI Ratnikov","year":"2017","unstructured":"Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W. & Ronai, Z. A. Metabolic rewiring in melanoma. Oncogene 36, 147\u2013157 (2017).","journal-title":"Oncogene"},{"key":"727_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pcmr.12661","volume":"31","author":"GM Fischer","year":"2018","unstructured":"Fischer, G. M., Vashisht Gopal, Y. N., McQuade, J. L., Peng, W., DeBerardinis, R. J. & Davies, M. A. Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications. Pigment Cell Melanoma Res. 31, 11\u201330 (2018).","journal-title":"Pigment Cell Melanoma Res."},{"key":"727_CR16","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3349\/ymj.2010.51.3.460","volume":"51","author":"HS Lee","year":"2010","unstructured":"Lee, H. S., Kim, H. J., Choi, S., Kim, C. K., Lee, N. S., Lee, K. T. et al. A case of type B lactic acidosis in acute leukemia. Yonsei Med. J. 51, 460\u2013462 (2010).","journal-title":"Yonsei Med. J."},{"key":"727_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fonc.2018.00232","volume":"8","author":"C Brault","year":"2018","unstructured":"Brault, C., Zerbib, Y., Delette, C., Marc, J., Gruson, B., Marolleau, J. P. et al. The Warburg effect as a type B lactic acidosis in a patient with acute myeloid leukemia: a diagnostic challenge for clinicians. Front. Oncol. 8, 232 (2018).","journal-title":"Front. Oncol."},{"key":"727_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.ajkd.2013.03.036","volume":"62","author":"P Sia","year":"2013","unstructured":"Sia, P., Plumb, T. J. & Fillaus, J. A. Type B lactic acidosis associated with multiple myeloma. Am. J. Kidney Dis. 62, 633\u2013637 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"727_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/pgmj.65.760.120","volume":"65","author":"AA McConnell","year":"1989","unstructured":"McConnell, A. A., Parfitt, V. L. & Walker, P. R. An unusual case of shock in a young woman. Postgrad. Med. J. 65, 120 (1989).","journal-title":"Postgrad. Med. J."},{"key":"727_CR20","first-page":"194","volume":"10","author":"AM Espinoza","year":"2011","unstructured":"Espinoza, A. M. & Venook, A. P. Lactic acidosis and colon cancer: oncologic emergency? Clin. Colorectal Cancer 10, 194\u2013197 (2011).","journal-title":"Clin. Colorectal Cancer"},{"key":"727_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000430445","volume":"24","author":"JD Krimmel","year":"2015","unstructured":"Krimmel, J. D. & Packer, C. D. Type B lactic acidosis in a patient with gastric adenocarcinoma and extensive hepatic metastases. Med. Princ. Pract. 24, 391\u2013393 (2015).","journal-title":"Med. Princ. Pract."},{"key":"727_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/pgmj.64.752.475","volume":"64","author":"KS Rao","year":"1988","unstructured":"Rao, K. S., Mehta, R. & Ferlinz, J. Unusual presentation of cancer-induced lactic acidosis. Postgrad. Med. J. 64, 475 (1988).","journal-title":"Postgrad. Med. J."},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/pgmj.62.726.297","volume":"62","author":"DS Sheriff","year":"1986","unstructured":"Sheriff, D. S. Lactic acidosis and small cell carcinoma of the lung. Postgrad. Med. J. 62, 297\u2013298 (1986).","journal-title":"Postgrad. Med. J."},{"key":"727_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/archinte.1981.00340060124034","volume":"141","author":"G Wesbey","year":"1981","unstructured":"Wesbey, G. Lactic acidosis in oat cell carcinoma with extensive hepatic metastases. Arch. Intern Med. 141, 816\u2013817 (1981).","journal-title":"Arch. Intern Med."},{"key":"727_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0169-5002(98)00081-6","volume":"22","author":"M Fujimura","year":"1998","unstructured":"Fujimura, M., Shirasaki, H., Kasahara, K. & Matsuda, T. Small cell lung cancer accompanied by lactic acidosis and syndrome of inappropriate secretion of antidiuretic hormone. Lung Cancer 22, 251\u2013254 (1998).","journal-title":"Lung Cancer"},{"key":"727_CR26","first-page":"6148350","volume":"2017","author":"DJ Oh","year":"2017","unstructured":"Oh, D. J., Dinerman, E., Matthews, A. H., Aron, A. W. & Berg, K. M. Refractory lactic acidosis in small cell carcinoma of the lung. Case Rep. Crit. Care. 2017, 6148350 (2017).","journal-title":"Case Rep. Crit. Care."},{"key":"727_CR27","doi-asserted-by":"crossref","unstructured":"Otten, M., Sepehrkhouy, S., van Everdingen, K. & Haas, L. Primary small cell carcinoma of the liver, a rare entity. BMJ Case Rep. 2013, bcr2013201990 (2013).","DOI":"10.1136\/bcr-2013-201990"},{"key":"727_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/jjco\/hyf050","volume":"32","author":"WK Chau","year":"2002","unstructured":"Chau, W. K., Yang, C. F., Chou, Y. H. & Ho, C. H. Aggressive undifferentiated carcinoma of unknown primary site complicated by lactic acidosis after bleeding: a case report. Jpn. J. Clin. Oncol. 32, 210\u2013214 (2002).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"727_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4103\/1319-2442.144266","volume":"25","author":"T El Imad","year":"2014","unstructured":"El Imad, T., El Khoury, L. & Geara, A. S. Warburg\u2019s effect on solid tumors. Saudi J. Kidney Dis. Transpl. 25, 1270\u20131277 (2014).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"727_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/00043426-200411000-00021","volume":"26","author":"JC Cheng","year":"2004","unstructured":"Cheng, J. C., Esparza, S. D., Knez, V. M., Sakamoto, K. M. & Moore, T. B. Severe lactic acidosis in a 14-year-old female with metastatic undifferentiated carcinoma of unknown primary. J. Pediatr. Hematol. Oncol. 26, 780\u2013782 (2004).","journal-title":"J. Pediatr. Hematol. Oncol."}],"updated-by":[{"DOI":"10.1038\/s41416-020-0801-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000}}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0727-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0727-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0727-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:25Z","timestamp":1684616845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-0727-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4,14]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-0727-8","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41416-020-0801-2","asserted-by":"object"}]},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41416-020-0801-2","URL":"https:\/\/doi.org\/10.1038\/s41416-020-0801-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The clinical trial of AZD3965 is ethically approved by the Newcastle and North Tyneside Regional Ethics Committee 1 (REC number 12\/NE\/0345) and run according to the standards of Good Clinical Practice as set out in the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave separate informed consent for publication of his case and the associated images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"There are no raw data published in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The AZD3965 clinical trial is sponsored and funded by the Cancer Research UK Centre for Drug Development. The patient was cared for at the Newcastle Experimental Cancer Medicine Centre, which is jointly funded by the Cancer Research UK and the Department of Health, UK (grant number RES\/0190\/7915). The urine lactate studies were performed at the Imperial College London Experimental Cancer Medicine Centre under a statement of work funded by CRUK (grant number CRUKD\/12\/004). Immunohistochemistry was performed in the MRC\/EPSRC Newcastle Molecular Pathology Node under a Specialist Unit Agreement with CRUK.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}